21. November 2009 00:21
Meaningful and lasting progress in addressing global health challenges cannot be achieved without partnerships and collaboration, according to a publication released today, Case Studies for Global Health.
[More]
18. November 2009 07:17
Sinovac Biotech Ltd., a leading developer and provider of vaccines in China, announced today that it received a revised production license from State Food and Drug Administration for Panflu.1, the Company's H1N1 vaccine. The population has been expanded to include people over 60 years old. The shelf life for PANFLU.1 was extended to one year from six months.
[More]
7. November 2009 02:10
The scientific ability to quickly and accurately identify species through DNA "barcoding" is being embraced and applied by a growing legion of global authorities - from medical and agricultural researchers to police and customs authorities to palaeontologists and others.
[More]
27. October 2009 08:41
Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced today that it has received its third purchase order for its H1N1 vaccine, PANFLU.1, from China's Ministry of Industry and Information Technology for the national stockpiling plan.
[More]
23. October 2009 00:28
Wednesday's release of the WHO, UNICEF and the World Bank joint report on childhood vaccines highlighted gains in recent global vaccination campaigns and also found that nearly 24 million infants worldwide don't get the recommended first-year vaccination.
[More]
a9c7da69-b834-46c0-a295-88102788bbbe|0|.0
Posted in: Child Health News | Healthcare News
Tags: Diphtheria, Hepatitis B, Immunization, Japanese Encephalitis, Measles, Pneumococcal Disease, Polio, Rotavirus, Smallpox, Tetanus, Tuberculosis, Vaccine, Yellow Fever
7. October 2009 03:54
Research at the University of Liverpool has supported the vaccination of more than 50 million people against a zoonotic brain infection that affects thousands of children across Asia every year.
[More]
6. October 2009 03:58
Inviragen and SingVax have merged their complementary vaccine pipelines and their international product development capabilities to create a company that is developing a wide range of vaccines for infectious diseases prevalent in emerging economies.
[More]
55e067bf-a7a4-432c-917b-25b3981c5239|0|.0
Posted in: Business / Finance | Pharmaceutical News
Tags: Biotechnology, Dengue Fever, H1N1, H5N1, Hemorrhagic Fever, Influenza, Investment, Japanese Encephalitis, Malaria, Smallpox, Vaccine, Virus
25. September 2009 06:34
The global market for human vaccines has experienced strong growth through 2008 and this is expected to continue through the forecast period. Growth will be fueled by new product introductions and rising usage in all regions.
[More]
954d8bad-30f6-4904-8bea-62d8ee5d74ac|0|.0
Posted in: Pharmaceutical News
Tags: Allergy, Anthrax, Botulism, Cancer, CDC, Cervical Cancer, Cholera, Diphtheria, DNA, Haemophilus influenzae Type B, Hepatitis B, Hepatitis C, HIV/AIDS, Immunization, Influenza, Japanese Encephalitis, Leishmaniasis, Malaria, Measles, Mumps, Pandemic, Pfizer, Pneumococcal Disease, Polio, Rotavirus, Shingles, Smallpox, Tetanus, Tuberculosis, Tularemia, Typhoid Fever, Vaccine, Virus, West Nile Virus, Yellow Fever
25. September 2009 05:09
Reportlinker.com announces that a new market research report is available in its catalogue.
[More]
da63794f-cfff-4ed9-957e-a5e1ac4a8de1|0|.0
Posted in: Pharmaceutical News
Tags: Allergy, Biotechnology, Breast Cancer, Cancer, Cell, Colorectal Cancer, DNA, Evolution, Gene Expression, Gene Therapy, Genomics, Influenza, Japanese Encephalitis, Lab-on-a-Chip, Leishmaniasis, Leukemia, Lung Cancer, Melanoma, Nanotechnology, Pancreatic Cancer, Pfizer, Prostate Cancer, Proteomics, Vaccine, Viral Vector, Virus, West Nile Virus
19. August 2009 07:41
Sinovac Biotech Ltd. announced today positive top-line results from the completed clinical trial for its internally-developed H1N1 vaccine. The clinical data unblinding conference was held in Beijing on the afternoon of August 17, 2009. Notably, Sinovac is the first company worldwide to complete clinical trials for the H1N1 vaccine.
[More]
c651ce18-0655-423a-a1c1-f90f5f89b765|0|.0
Posted in: Drug Trial News
Tags: Antibody, Blindness, CDC, H1N1, H5N1, Immunization, Influenza, Japanese Encephalitis, Pandemic, Swine Flu, Vaccine
30. March 2009 22:49
Intercell AG (VSE: ICLL) today announced that the U.S. Food and Drug Administration (FDA) approved IXIARO(R), a new vaccine for the prevention of Japanese Encephalitis (JE).
[More]
2056eb3a-bf87-4e95-a7d0-d09c5f122831|0|.0
Posted in: Pharmaceutical News
Tags: Biotechnology, Brain, Diarrhea, Gastroesophageal Reflux Disease (GERD), Immunization, Influenza, Japanese Encephalitis, Neurological Disease, Pandemic, Vaccine, Virus
30. March 2009 18:12
The U.S. Food and Drug Administration has approved IXIARO, a vaccine to prevent Japanese encephalitis (JE) which is caused by a mosquito-transmitted virus found mainly in Asia. IXIARO will be the only vaccine for JE available in the United States.
[More]
8. July 2008 03:47
Japanese encephalitis (JE), commonly known as brain fever, is one of the prevalent mosquito-borne encephalitis in India and entire South East (SE) Asia.
[More]
27. May 2008 15:42
The next generation of insect repellents could be in the pipeline with research from the U.S. suggesting seven possibilities.
[More]
20. February 2008 14:18
Two researchers from National Brain Research Center (NBRC) suggest that a common antibiotic called minocycline may prevent children from death due to Japanese encephalitis (JE), or commonly known as brain fever.
[More] 
Subscribe